Patogénesis de las enfermedades neuronales autoinmunes
Publicaciones destacadas
-
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study
Guasp, Mar; Simabukuro, Mateus Mistieri; Munoz-Sanchez, Guillermo; Brenner, Juliette; Wurdack, Katharina;(...)Titulaer, Maarten J; Armangue, Thais; Graus, Francesc; Iizuka, Takahiro; Dalmau, Josep.Referencia:LANCET NEUROLOGY 2026.
-
Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis
Maudes, Estibaliz; Planaguma, Jesus; Marmolejo, Laura; Radosevic, Marija; Serafim, Ana Beatriz;(...)Spatola, Marianna; Loza-Alvarez, Pablo; Sabater, Lidia; Matute, Carlos; Dalmau, Josep.Referencia:BRAIN 2025.
-
Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis
Olive-Cirera, Gemma; Fonseca, Elianet; Chen, Li-Wen; Fetta, Anna; Martinez-Hernandez, Eugenia;(...)Blanco, Yolanda; Saiz, Albert; Graus, Francesc; Dalmau, Josep; Armangue, Thais.Referencia:LANCET NEUROLOGY 2025.
-
Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study
Muñoz-Lopetegi, A; Guasp, M; Prades, L; Martínez-Hernández, E; Rosa-Justícia, M;(...)Castro-Fornieles, J; Compte, A; Gaig, C; Santamaria, J; Dalmau, J.Referencia:LANCET NEUROLOGY 2024.
-
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies
Armangué, T; Olivé-Cirera, G; Martínez-Hernandez, E; Rodes, M; Peris-Sempere, V;(...)Vanderver, A; Casanova, JL; Zhang, SY; Dalmau, J; Spanish HSE Study Grp.Referencia:BRAIN 2023.
-
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
Guasp, Mar; Rosa-Justicia, Mireia; Munoz-Lopetegi, Amaia; Martinez-Hernandez, Eugenia; Armangue, Thais;(...)Sanchez-Valle, Raquel; Santamaria, Joan; Compte, Albert; Castro-Fornielest, Josefina; Dalmau, Josep.Referencia:LANCET NEUROLOGY 2022.
-
Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice
Radosevic, Marija; Planaguma, Jesus; Mannara, Francesco; Mellado, Araceli; Aguilar, Esther;(...)Garcia-Serra, Anna; Maudes, Estibaliz; Gasull, Xavier; Lewis, Mike; Dalmau, Josep.Referencia:Neurology-Neuroimmunology & Neuroinflammation 2022.
-
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Gaig, Carles; Compta, Yaroslau; Heidbreder, Anna; Marti, Maria J; Titulaer, Maarten J;(...)Sabater, Lidia; Iranzo, Alex; Cano, Joan Santamaria; Dalmau, Josep; Graus, Francesc.Referencia:NEUROLOGY 2021.
-
Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis
Guasp, Mar; Gine-Serven, Eloi; Maudes, Estibaliz; Rosa-Justicia, Mireia; Martinez-Hernandez, Eugenia;(...)Saiz, Albert; Graus, Francesc; Castro-Fornieles, Josefina; Parellada, Eduard; Dalmau, Josep.Referencia:NEUROLOGY 2021.
-
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
Armangue, T; Olivé-Cirera, G; Martínez-Hernandez, E; Sepulveda, M; Ruiz-Garcia, R;(...)Montalban, X; Vanderver, A; Graus, F; Saiz, A; Dalmau, J.Referencia:LANCET NEUROLOGY 2020.
